Drugs / 90Y-DOTA-Epratuzumab
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02577094 | ? → Jan 2017 | B-cell acute lymphoblastic leukemia | Nantes University Hospital | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 90Y-DOTA-Epratuzumab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02577094 ↗ |